Dietary sodium restriction and natriuresis in management of hypertension.
D000328:Adult; D000368:Aged; D001581:Benzothiadiazines; D004039:Diet, Sodium-Restricted; D004232:Diuretics; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D006974:Hypertension, Malignant / Q000188:drug therapy; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D009318:Natriuresis; D012110:Reserpine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D008750:Methyldopa; D005665:Furosemide; D012110:Reserpine; D004976:Ethacrynic Acid; D006145:Guanethidine